Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm

V. S. Renukuntla; N. Ramchandani; J. Trast; M. Cantwell; R. A. Heptulla

doi:10.1089/dia.2016.2504

Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm

V. S. Renukuntla, N. Ramchandani, J. Trast, M. Cantwell, R. A. Heptulla

Pediatrics

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	S39-S40
Journal	Diabetes Technology and Therapeutics
Volume	18
DOIs	https://doi.org/10.1089/dia.2016.2504
State	Published - Feb 2016

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology
Medical Laboratory Technology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1089/dia.2016.2504

Cite this

@article{5a57e2d299db4c4c9c1feae28f2ef539,

title = "Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm",

author = "Renukuntla, {V. S.} and N. Ramchandani and J. Trast and M. Cantwell and Heptulla, {R. A.}",

year = "2016",

month = feb,

doi = "10.1089/dia.2016.2504",

language = "English (US)",

volume = "18",

pages = "S39--S40",

journal = "Diabetes Technology and Therapeutics",

issn = "1520-9156",

publisher = "Mary Ann Liebert Inc.",

}

TY - JOUR

T1 - Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm

AU - Renukuntla, V. S.

AU - Ramchandani, N.

AU - Trast, J.

AU - Cantwell, M.

AU - Heptulla, R. A.

PY - 2016/2

Y1 - 2016/2

UR - http://www.scopus.com/inward/record.url?scp=84957627215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957627215&partnerID=8YFLogxK

U2 - 10.1089/dia.2016.2504

DO - 10.1089/dia.2016.2504

M3 - Comment/debate

AN - SCOPUS:84957627215

SN - 1520-9156

VL - 18

SP - S39-S40

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

ER -

Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this